Murli Krishna Pharma Pvt. Ltd. Pune, Maharashtra

• Country of OriginIndia
• MOQ200kg
• USPtest 4, test 6

Release pattern compared with innovator  Flomax. MKPPL objective is to develop Tamsulosin hydrochloride SR pellets by aqueous phase and pellets developed by aqueous technology had better advantage of avoiding the use of organic solvents. In case of fluid bed coater, to achieve the desired sustained release profile equivalent to innovator, MKPPL drug loaded pellets will be coated with polymers, either single polymer or in combination with different ratios. In case of extrusion Spheronization, Tamsulosin hydrochloride SR pellets can be develop by preparing wet mass of API & Excipients. Offer complete technical package for registrations in all regulated/semi regulated markets. Percentage:0.12%, 0.13%, 0.16%, 0.20%, Release Type:Extended Release, Target Formulations:Capsules, Documentation Available:DMF in CTD Format.

Orlistat pellets 50%w/w-A pre-finished formulation of Orlistat is in Pellets 50% is in form of enteric coated Pellets produced by using Aqueous Base technology. -Orlistat is a drug designed to treat obesity. -We offer Orlistat Pellets product in the form of Pellets with a drug loading of 50%. -We offer in mesh size of 18#30 -Since the Product is Non Pharmacopoeial, our product complies with stringent In House Specs We have the Technical Package ready for the product. Advantages: -Ready to fill any size of capsules. -No processing prior to capsule and dry syrup filling resulting in substantial cost and time saving. - Better in-vitro and in-vivo absorption profile (matching with innovator’s profile) for long term Pharmacological action. -The plant has been audited & approved for GMP compliance as per ICH guidelines & manufacturing by European Union (EU), WHO-GMP; vide statutory site audits by Indian FDA, Local GMP issued by FDA. -The only pelletization unit in India that has been accorded the status of being a 100% Export Oriented Unit (EOU). Packaging Details: 25 Kg HDEP drum

• Aqueous base formulationsno solvent
• fine spherical pellets-disso. profile matches with innovators brand

Omeprazole Enteric-Coated Pellets It is the Proton Pump Inhibitors (PPI), used for the treatment of acidity and ulcers. It is available in the form of pellets. It’s a site specific product and enteric release order. Variation of the products: Percentage: 7% to 20% Used for various application in Oral Dosage Form. Used also in Combination Dosage Forms, Suspensions, Micro-pellets for compressing into tablets. Mesh Size: 12to14, 14to16, 16to 18, 18to20, 20to22, 22to24, 24to30, 30to40, 40to60 Document Available EDMF, USDMF available. BA/BE studies conducted in Greece on Omeprazole 40 mg (Dossier available with our buyer). Registration: DMF logged in US and Europe